Literature DB >> 4153105

The binding of sulphonylureas to serum albumin.

M J Crooks, K F Brown.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4153105     DOI: 10.1111/j.2042-7158.1974.tb09280.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  16 in total

1.  Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.

Authors:  K S Joseph; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-06-01       Impact factor: 3.205

2.  Possible protein binding displacement interaction between glibenclamide and metolazone.

Authors:  S George; A McBurney; A Cole
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

5.  Association of upregulated activity of K(ATP) channels with impaired insulin secretion in UCP1-expressing insulinoma cells.

Authors:  Mitsuhiro Nakazaki; Masafumi Kakei; Hisamitsu Ishihara; Nobuyuki Koriyama; Hiroshi Hashiguchi; Katsumi Aso; Michiyo Fukudome; Yoshitomo Oka; Toshihiko Yada; Chuwa Tei
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

6.  Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin.

Authors:  Xiwei Zheng; Ryan Matsuda; David S Hage
Journal:  J Chromatogr A       Date:  2014-10-31       Impact factor: 4.759

Review 7.  The management of diabetes mellitus in older individuals.

Authors:  J E Morley; H M Perry
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

8.  Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Jeanethe Anguizola; K S Joseph; David S Hage
Journal:  J Chromatogr A       Date:  2012-10-08       Impact factor: 4.759

9.  Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

10.  Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography.

Authors:  Pingyang Tao; Zhao Li; Ashley G Woolfork; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2019-01-14       Impact factor: 3.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.